Table 2.
Comparison between the two groups at 1, 3 and 6 months after therapy.
1 Month | p-Value | 3 Months | p-Value | 6 Months | p-Value | ||
---|---|---|---|---|---|---|---|
IPSS score | Group A | 6.45 ± 4.8 | 0.020 | 5.32 ± 4.63 | 0.042 | 4.91 ± 4.47 | 0.005 |
Group B | 4.31 ± 4.35 | 3.20 ± 3.05 | 2.63 ± 3.28 | ||||
NIH-CPSI total score | Group A | 16.15 ± 3.31 | <0.0001 | 13.47 ± 3.07 | <0.0001 | 9.83 ± 2.53 | <0.0001 |
Group B | 13.10 ± 5.03 | 9.65 ± 4.23 | 5.51 ± 2.84 | ||||
NIH-CPSI pain domain score | Group A | 5.83 ± 2.57 | 0.011 | 4.55 ± 2.54 | <0.0001 | 3.09 ± 2.12 | <0.0001 |
Group B | 5.04 ± 4.66 | 3.18 ± 4.13 | 1.31 ± 2.13 | ||||
NIH-CPSI urinary domain score | Group A | 4.89 ± 1.38 | <0.0001 | 4.23 ± 1.11 | 0.004 | 3.02 ± 1.03 | 0.005 |
Group B | 3.76 ± 1.33 | 3.51 ± 1.24 | 2.43 ± 1.06 | ||||
NIH-CPSI QoL domain score | Group A | 4.89 ± 1.38 | <0.0001 | 4.68 ± 0.98 | <0.0001 | 3.72 ± 1.26 | <0.0001 |
Group B | 3.76 ± 1.33 | 2.96 ± 1.24 | 1.78 ± 1.34 |